Self-limited neonatal epilepsy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
Nov 2022

Sezaby: FDA approved

treatment of neonatal seizures in term and preterm infants

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

Patient Assistance Programs1

Sezaby

Sun Pharmaceutical Industries, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Sezaby

(phenobarbital sodium)Orphan drug

Sun Pharmaceutical Industries, Inc.

Approved Nov 2022FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Self-limited neonatal epilepsy.
Search all trials →
Search clinical trials for Self-limited neonatal epilepsy

Recent News & Research

No recent news articles indexed yet for Self-limited neonatal epilepsy.
Search PubMed for Self-limited neonatal epilepsy

Browse all Self-limited neonatal epilepsy news →

Specialist Network

No specialists currently listed for Self-limited neonatal epilepsy.

View all Self-limited neonatal epilepsy specialists →

Quick Actions